Alternating bowel pattern: what do people mean?

Size: px
Start display at page:

Download "Alternating bowel pattern: what do people mean?"

Transcription

1 Alimentary Pharmacology & Therapeutics Alternating bowel pattern: what do people mean? R. S. CHOUNG*, G. R. LOCKE III*, A. R. ZINSMEISTER, L.J.MELTONIIIà &N.J.TALLEY* *Dyspepsia Center and Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN; Department of Health Sciences Research Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, MN; àdivision of Clinical Epidemiology, Mayo Clinic College of Medicine, Rochester, MN, USA Correspondence to: Dr G. R. Locke III, Professor of Medicine, Mayo Clinic, 200 First Street SW, W-19A, Rochester, MN 55905, USA. Publication data Submitted 27 January 2006 First decision 14 February 2006 Resubmitted 20 March 2006 Accepted 3 April 2006 SUMMARY Background With the introduction of new therapies, the subgrouping of patients based on bowel pattern has become important. However, the appropriate definition of an alternating bowel pattern remains unclear. Aim To determine if specific symptoms are reported by people with an alternating bowel pattern. Methods Using the Rochester Epidemiology Project, a series of population-based surveys were undertaken in which valid self-report gastrointestinal symptom questionnaires were mailed to 4029 randomly selected members of the community. One question asked was How would you describe your usual bowel pattern in the last year? Results 3022 subjects (74%) provided questionnaire data and 2718 were eligible for this analysis, the mean age was 57 years, with a range of years (median ¼ 61). Of these, 9.2%, 2.5% and 7.6% reported their usual bowel pattern as being constipated, diarrhoea, or alternating respectively. At least 50% of those reporting alternating bowel pattern reported incomplete evacuation (63%), urgency (57%), straining (55%) and loose stool (50%). The proportion of alternators reporting each individual symptom was between that of diarrhoea and constipation except for mucus and incomplete evacuation; however, no symptom was unique to alternators. Conclusion People who self-report an alternating bowel pattern appear to represent a blend of constipation and diarrhoea symptoms, rather than a distinct subgroup. Aliment Pharmacol Ther 23, ª 2006 The Authors 1749 doi: /j x

2 1750 R. S. CHOUNG et al. INTRODUCTION Recently two new therapies, alosetron and tegaserod, have been developed for irritable bowel syndrome (IBS). It is important to note that they have very different effects. 1 4 Alosetron helps diarrhoea-predominant IBS (IBS-D) 1, 2 whereas tegaserod helps constipation-predominant IBS (IBS-C). 3, 4 The development of these therapies has therefore led to a need to subclassify IBS. Thus, the Rome committees suggested definitions for IBS-D and IBS-C. 5, 6 This subgrouping leaves a group of people with IBS who are neither constipation-predominant nor diarrhoea-predominant; they may have both or they may have neither. The terms alternating IBS and mixed IBS have recently been used to define these groups. 7, 8 At present, the appropriate definition of an alternator is not clear. Drossman et al. 9 suggested that mixed IBS is not fulfilling criteria for either IBS-C or IBS-D, whereas alternating IBS is a change in bowel habit over time. Rather than impose definitions, however, we sought to understand what comprised an alternating bowel pattern by allowing people in the community to selfreport their typical bowel pattern. Our aim was to determine if a specific set of symptoms was associated with people reporting an alternating bowel pattern. MATERIALS AND METHODS Subjects The Olmsted County, MN population comprises approximately subjects, of which 90% are white; sociodemographically, the community is similar to the United States white population. 10 Over 95% of County residents receive their medical care from one of the two group practices in the community (Mayo Medical Center and Olmsted Medical Center). Mayo Clinic has maintained a common medical record system with its two affiliated hospitals (Saint Marys and Rochester Methodist) for over 90 years. Recorded diagnoses and surgical procedures are indexed, including the diagnoses made for out-patients seen in office or clinic consultations, emergency room visits or nursing home care, as well as the diagnoses recorded for hospital in-patients, at autopsy examination or on death certificates. This system was further developed by the Rochester Epidemiology Project, which created similar indices for the records of other providers of medical care to local residents, most notably the Olmsted Medical Group and its affiliated Olmsted Community Hospital (Olmsted Medical Center). Thus, details of the medical care provided to the residents of the County are available for study. Annually, over 80% of the entire population is attended by one or both of these two practices, and nearly everyone is seen at least once during any given 3-year period. 10 Therefore, the Rochester Project medical records linkage system also provides what is essentially an enumeration of the population from which samples can be drawn. As approved by the Institutional Review Boards of the Mayo Clinic and Olmsted Medical Center, we used this system previously to draw a series of random samples of Olmsted County residents stratified by age (5-year intervals between 20 and 94 years) and sex (equal numbers of men and women). Survey methods As part of previous investigations, these randomly selected Olmsted County residents were mailed valid self-report gastrointestinal (GI) symptom questionnaires. The Bowel Disease Questionnaire (BDQ) was mailed to subjects years of age, and the Elderly Bowel Syndrome Questionnaire (EBSQ) was mailed to subjects years of age. The questionnaires have been shown to be understandable, easily completed and to have adequate validity. 13, 14 The BDQ consists of 46 GI symptoms, while the EBSQ has 33 symptom items; 26 of these items are identical on both questionnaires, and these were considered in the analysis. The BDQ also included the Somatic Symptom Checklist (SSC), whereas the EBDQ did not. This checklist consists of 12 non-gi and five GI symptoms or illnesses, and subjects are instructed to indicate how often each symptom occurred (0 ¼ not a problem to 4 ¼ occurs daily) and how bothersome each was (0 ¼ not a problem to 4 ¼ extremely bothersome when occurs) during the past year, using separate 5-point scales. The study questionnaire and an explanatory letter were mailed to this age- and gender-stratified sample of 4029 residents of Olmsted County. Reminder letters were mailed at weeks 2, 4 and 7 to non-responders. Subjects who indicated at any point that they did not wish to complete the survey were not contacted further. Otherwise, non-responders were contacted by telephone at week 10 to request their participation and verify their residence within the County. A completed questionnaire was returned by 3022 subjects, giving a response rate of 74%. Among the 3022 subjects who

3 ALTERNATING BOWEL HABITS 1751 completed a questionnaire, 304 (10.1%) had subsequently denied authorization to use their medical records for research, 15 leaving 2718 subjects for this analysis. The questionnaires included one question that asked, How would you describe your usual bowel pattern in the last year? The response options were normal, constipated [self-reported constipation (SRC)], diarrhoea (SRD), and alternating constipation and diarrhoea (SRA). This question was used to define the study groups used in the analysis. The reliability of this specific question regarding self-reported bowel habit was 0.72 (95% CI: ) with 89% agreement 14 and the median j-statistic for all questions was Three GI symptom complexes were defined by specific symptom criteria, as follows: Constipation Defined as two or more of the following complaints in the prior 12 months: straining >25% of the time, hard stools >25% of the time, feeling of incomplete evacuation >25% of the time, or <3 stools/week >25% of the time. Diarrhoea Defined as two or more of the following complaints in the prior 12 months: loose or watery stools >25% of the time, urgency >25% of the time, or more than 3 stools/day >25% of the time. Irritable bowel syndrome Defined as abdominal pain more than six times in the prior year, in combination with two or more of the following symptoms (referred to as the Manning symptom criteria): 18 (i) pain that was often relieved by defecation (more than 25% of the time); (ii) looser stools often when pain began; (iii) more frequent stools often when pain began; (iv) abdominal distension often; (v) a feeling of incomplete evacuation often and (vi) mucus per rectum. Statistical methods To identify symptoms that are described differently among groups defined by their self-reporting of bowel pattern (normal, constipation, diarrhoea, alternating), logistic regression models were examined in which each individual symptom was considered as the dependent variable and bowel pattern groups (as dummy regression variables) were the predictors. In addition to the individual symptoms (i.e. straining, urgency, incomplete evacuation, hard stool, bowel movement frequency, loose bowel movement, pain frequency, mucus, pain severity and pain relief by bowel movement), three symptom complexes (i.e. constipation, diarrhoea, IBS) were also assessed as response (dependent) variables in separate logistic regression models. A generalized logit link function was used for symptoms with more than two categories (e.g. pain frequency). The regression models were set up with normal bowel pattern group as the reference level (i.e. SRC, SRD, SRA vs. normal) and specific pairwise contrasts of the regression coefficients were used to obtain the odds ratio (OR) for each symptom (or symptom complex) for SRA relative to SRC and SRA relative to SRD. Odds ratios and 95% confidence intervals (CI) were calculated based on the estimated regression coefficients and their standard errors from the logistic regression models. All P-values were two-sided, and P-values <0.05 were considered statistically significant. In addition, these models were analysed separately for those above and below 60 years of age. RESULTS Of the 2718 Olmsted County residents who were eligible for this analysis, the mean (s.d.) age was 57 (19) years, with a range of years (median ¼ 61); 63% were women. The proportions reporting each bowel pattern were as follows: 9.2% had SRC, 2.5% had SRD and 7.6% had SRA. The 206 subjects with SRA had a mean age of 54 years, and 63% were female. Subjects reporting SRA had smaller ORs for being older than 50 years relative to those reporting normal bowel pattern or SRC, and greater ORs for being female than those reporting a normal bowel pattern. A subset of subjects had been mailed questionnaires containing the SSC, and among the corresponding respondents, a total of 1462 subjects (54.4%) completed the items to compute an SSC score (55.3%, 34.4%, 73.9%, 62.6% in those reporting normal, constipation, diarrhoea and alternating bowel habit, respectively), SSC scores were significantly higher in SRA (vs. normal and SRC, P < 0.005) but not different from SRD. Among those in the SRA group, 39% reported bowel function consistent with a classification of constipation only, 16% with diarrhoea

4 1752 R. S. CHOUNG et al. % Constipation only Diarrhoea only only, 20% with both, and 25% neither bowel pattern. Figure 1 shows the proportion by gender of those with SRA who met criteria for constipation only, diarrhoea only, both and neither. No significant gender differences were noted. Overall 16% of subjects met IBS by Manning criteria. Among subjects meeting Manning IBS criteria, 19% reported a constipation bowel habit, 8% diarrhoea, 23% alternating and 50% normal bowel habit. Among subjects not meeting Manning IBS criteria, 7% 20 Both Male Female Neither Figure 1. Percentage of Olmsted County, MN residents with self-reported alternating bowel pattern (n ¼ 206) who met symptom criteria for constipation only, diarrhoea only, both, or neither. reported a constipation bowel habit, 1% diarrhoea, 4% alternating and in 86% a normal bowel habit. Among subjects with SRC, 33% met Manning criteria for IBS, among those SRD, 54% met Manning IBS criteria and among those reporting SRA, 50% met Manning criteria for IBS, while in those reporting a normal bowel habit, 10% met Manning IBS criteria. The ORs for meeting symptom criteria of constipation were increased for SRA vs. normal (OR ¼ 10.6, 95% CI: ) and vs. SRD (OR ¼ 15.2, 95% CI: ) but decreased vs. SRC (OR ¼ 0.3, 95% CI: ). Correspondingly, the ORs for meeting symptom criteria of diarrhoea were increased in SRA vs. normal (OR ¼ 11.6, 95% CI: ) and vs. SRC (OR ¼ 27.5, 95% CI: ) but decreased relative to SRD (OR ¼ 0.2, 95% CI: ). The ORs for IBS were increased in SRA relative to normal (OR ¼ 8.7, 95% CI: ) and relative to SRC (OR ¼ 2.0, 95% CI: ) but not SRD (OR ¼ 0.9, 95% CI: ). The distribution of individual abdominal symptoms among the bowel pattern subgroups is summarized in Table 1. As expected, symptoms of constipation and diarrhoea were frequently reported by people with SRC and SRD, respectively. Among the subjects with SRA, just over half reported incomplete evacuation (63%), urgency (57%), straining (55%) and loose stool (50%; Table 1). Also among SRA, 35% reported mucus that Symptom Percentage of the following subgroups with symptom Normal (n ¼ 2164) Constipation (n ¼ 250) Diarrhoea (n ¼ 69) (n ¼ 206) Table 1. Demographic characteristics and abdominal symptoms among self-reported bowel pattern subgroups Age over 50 years Female gender Pain severe or very severe Pain several times each week or more Loose bowel movement Frequent BM Feeling of incomplete evacuation Mucus Urgency Straining Hard stool Bloating Pain relief with BM More BMs with pain BM, bowel movement.

5 ALTERNATING BOWEL HABITS 1753 was the highest proportion among the three groups. The reporting of feelings of incomplete rectal evacuation was 63% in SRA when compared with 60% in SRC and 42% in SRD. The ability of the self-report bowel pattern groups to predict individual symptoms is shown in Table 2. Logistic regression analysis indicated that all of the symptoms assessed (except for frequent bowel movements) were significantly associated with SRA relative to normal (P < 0.05). Significantly increased ORs in SRA relative to SRC were observed for urgency, frequent stools, loose stools, mucus, frequent and severe abdominal pain, while decreased ORs were observed for straining and hard stools. In comparing SRA with SRD, increased ORs for straining, hard stools and incomplete evacuation were observed, but ORs were decreased for urgency, frequent bowel movements and loose stools. We analysed these results separately for patients younger and older than 60 years of ago. However, we found there were no interaction by age for the associations between individual symptoms and self-reported bowel patterns. Thus, for constipation symptoms, the ORs were higher for SRA than SRD but lesser for SRA than SRC. For diarrhoea symptoms, the ORs were higher for SRA than SRC but lower for SRA than SRD. However, mucus and feelings of incomplete rectal evacuation were reported by a higher proportion of those with SRA than either SRC or SRD. For mucus per rectum, the association with SRA was significant compared with SRC but not SRD; for the feeling of incomplete evacuation the association with SRA was significant compared with SRD but not SRC. DISCUSSION Recently, questions about who is an alternator in IBS have increased because of its apparent frequency in IBS and the increasing need to accurately subclassify IBS for therapeutic targets. 19, 20 However, no criteria were suggested for the alternator IBS subgroup by the Rome committee, and despite a relative lack of attention, the alternator IBS subgroup appears to represent approximately one-third of IBS patients. 21, 22 In our study, we found the proportion with SRA bowel pattern to be high (7.6%) based on a community sample, in comparison, the proportion with SRD was 2.5% and SRC was 9.2%. There is actually little epidemiological data on self-reported alternating bowel habit. Our data are similar to the study of Agreus et al. 23 They reported the overall prevalence of alternating bowel pattern in a Swedish population-based study was 6.2%. Among those with SRA, 20% met symptom definitions of both constipation and diarrhoea by specific criteria, 39% met the definition of constipation and 16% met the definition of diarrhoea; 25% did not meet either definition. Among the 2718 subjects for whom full data were available, 444 (16%) met Manning criteria. This proportion of IBS is similar to previous studies. Talley Table 2. Associations between individual symptoms and selfreported bowel patterns [OR (95% CI)] Symptom vs. normal vs. constipation vs. diarrhoea Straining 8.0 ( )* 0.2 ( )* 20.2 ( )* Urgency 8.8 ( )* 6.2 ( )* 0.5 ( )* Incomplete evacuation 11.6 ( )* 1.2 ( ) 2.5 ( )* Hard stool 4.4 ( )* 0.2 ( )* 27.3 ( )* Frequent BM 2.0 ( ) 31.2 ( )* 0.1 ( )* Loose BM 5.1 ( )* 7.5 ( )* 0.5 ( )* Mucus 6.3 ( )* 3.1 ( )* 1.5 ( ) Pain severity 10.6 ( )* 2.5 ( )* 0.7 ( ) (severe/very severe) Pain relief by a BM 4.7 ( )* 1.5 ( ) 1.4 ( ) More BM with pain 4.9 ( )* 4.6 ( )* 0.5 ( )* Frequent pain (>1/week) 11.7 ( )* 2.6 ( )* 0.8 ( ) BM, bowel movement. * P < Odd ratios (95% CI) in alternator relative to normal, constipation and diarrhoea.

6 1754 R. S. CHOUNG et al. et al. 24 reported that the prevalence of IBS in a geriatric population sample is similar to the prevalence of a middle-age population sample. Interestingly, about 50% of the SRA group met the definition of IBS by the Manning criteria. Recent studies have tried to define an alternator group in IBS, but no consensus exists. Drossman et al. 9 suggested that an alternator in IBS patients be defined as at least one change between IBS-D and IBS-C by Rome II criteria over a 1-year period. However, they did not study whether different characteristics existed in alternators compared with constipation- or diarrhoea-type in IBS. Tillisch et al. 7 defined the subgroups of IBS using diagnostic criteria based on stool consistency. They suggested that stool consistency provided the most simple and specific means of characterizing alternators in patients with IBS. However, this study was not population-based, as subjects were recruited from a tertiary referral centre or by advertisement. Mearin et al. 20 reported that among those with IBS by Rome I criteria, 66% considered themselves to have constipation. Yet among the 38 people who had what they called alternating IBS by Rome I, just 8% reported constipation. Among 40 people with alternating IBS by Rome II, the majority had constipation but no actual numbers are given. A changing of the definition between Rome I and Rome II leads to very different results. In this study, the sample size of people with IBS-A and the subjects with IBS who self-reported having an alternating bowel patterns was quite small. In the Mearin et al. study, 20 among those who self-reported alternating bowel habit, about 30% had constipation, 30% had diarrhoea and about 40% had alternating IBS subtype. However, our study revealed, among subjects meeting Manning IBS criteria, 19% reported a constipation bowel habit, 8% diarrhoea, 23% alternating and 50% normal bowel habit. This highlights the issue of whether alternators include people with both diarrhoea and constipation or neither? We found that bowel symptoms were quite common in people with SRA. For most symptoms; the proportion in SRA was higher than normal and was between SRC and SRD. Two symptoms seemed different: the subjects with SRA reported passage of mucus and feelings of incomplete evacuation more often than people with SRD or SRC. However, our study could not identify a distinct subgroup of symptoms that were reported by alternators. Those with SRA had symptoms of both constipation and diarrhoea. Thus, self-reported alternating bowel pattern seems to suggests a combination of bowel patterns rather than a distinct pathophysiology. The strengths of the present study include the investigation of a random community sample who was not seeking health care for their bowel complaints, which should have minimized selection bias. The fact that we employed a previously validated self-report symptom questionnaire also increases confidence in the results. 13 Those with SRC had more constipation symptoms than other groups, while those with SRD had more diarrhoea symptoms than other groups. This may just suggests that these two groups are better at judging their bowel habit, as reported by Mearin et al. 20 This study also had limitations. In particular, prospective diary data were not available to confirm the self-reported information. These data cannot be generalized to the whole population because the racial composition of this community is predominantly Caucasian. 10 The prevalence of bowel pattern may vary across different countries and cultures, but at minimum our data are probably generalizable to the US Caucasian population. Comparable studies in other populations are necessary. Because our study population had a median age of 61 years, these results are more applicable to older individuals. Still we did not identify any significant age effects. We conclude from this population-based study that self-reporting an alternating bowel pattern is associated with passage of mucus and, to a lesser extent, the feeling of incomplete evacuation, but that people who self-report alternating bowel patterns cannot be classified into a distinct subgroup. Alternating bowel pattern appears to reflect a combined state of both constipation and diarrhoea. Further work to understand what characterizes an alternator, and the relationship between alternating bowel pattern, constipation and diarrhoea, is warranted. ACKNOWLEDGEMENTS This study was sponsored in part by Novartis Pharmaceuticals Corporation and the Mayo Foundation. The authors would like to thank Cathy Schleck for her assistance with data analysis and Mary Jo Philo for her assistance in the preparation of the manuscript.

7 ALTERNATING BOWEL HABITS 1755 REFERENCES 1 Camilleri M, Chey WY, Mayer EA, et al. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med 2001; 161: Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomized, placebo-controlled trial. Lancet 2000; 355: Novick J, Miner P, Krause R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16: Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001; 15: Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Mueller-Lissner SAC. Functional bowel disorders and D. Functional abdominal pain. In: Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment: a Multinational Consensus, 2nd edn. McLean, VA, USA: Degnon Associates, Inc., 2000: Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller- Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45: II Tillisch K, Labus JS, Naliboff BD, et al. Characterization of the alternating bowel pattern subtype in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: Guilera M, Balboa A, Mearin F. Bowel pattern subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100: Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel pattern in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005; 128: Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996; 71: Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors and health care utilization. Am J Epidemiol 1995; 142: Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1992; 102: Talley NJ, Phillips SF, Melton LJ, Wiltgen C, Zinsmeister AL. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: O Keefe EA, Talley NJ, Tangalos EG, Zinsmeister AR. A bowel symptom questionnaire for the elderly. J Gerontol 1992; 47: M Melton LJ III. The threat to medical records research. N Engl J Med 1997; 337: Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJ III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: Talley NJ, Boyce PM, Owen BK, Newman P, Paterson KJ. Initial validation of a bowel symptom questionnaire and measurement of chronic gastrointestinal symptoms in Australians. Aust N Z J Med 1995; 25: Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: Drossman DA, Camilleri M, Mayer EA, et al. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: Mearin F, Balboa A, Badia X, et al. Irritable bowel syndrome subtypes according to bowel pattern: revisiting the alternating subtype. Eur J Gastroenterol Hepatol 2003; 15: Walter SA, Skagerstrom E, Bodemar G. Subgroups of irritable bowel syndrome: a new approach. Eur J Gastroenterol Hepatol 2004; 16: Mearin F, Baro E, Roset M, Badia X, Zarate N, Perez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004; 99: Agreus L, Svardsudd K, Nyren O, Tibblin G. The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol 1994; 29: Talley NJ, O Keefe EA, Zinsmeister AR, Melton LJ III. Prevalence of gastrointestinal symptoms in the elderly: a population-based study. Gastroenterology 1992; 102:

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population

Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population https://helda.helsinki.fi Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population Hillilä, M. T. 2004-08-01 Hillilä, M T & Färkkilä, MA 2004,

More information

Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study)

Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study) Alimentary Pharmacology & Therapeutics Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study) V. GARRIGUES*, F. MEARIN, X.BADÍAà,

More information

A Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator

A Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator GASTROENTEROLOGY 2005;128:580 589 A Prospective Assessment of Bowel Habit in Irritable Bowel Syndrome in Women: Defining an Alternator DOUGLAS A. DROSSMAN,* CAROLYN B. MORRIS,* YUMING HU,* BRENDA B. TONER,

More information

T he irritable bowel syndrome (IBS) is a symptom complex

T he irritable bowel syndrome (IBS) is a symptom complex 1703 FUNCTIONAL BOWEL DISEASE Familial aggregation of irritable bowel syndrome: a prospective study J S Kalantar, G R Locke III, A R Zinsmeister, C M Beighley, N J Talley... Gut 2003;52:1703 1707 See end

More information

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey

Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey Aliment Pharmacol Ther 2005; 22: 935 942. doi: 10.1111/j.1365-2036.2005.02671.x Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey E. B. ANDREWS*, S. C. EATON*,

More information

Applying Case Definition Criteria to Irritable Bowel Syndrome

Applying Case Definition Criteria to Irritable Bowel Syndrome Clinical Medicine & Research Volume 6, Number 1:9-16 2008 Marshfield Clinic clinmedres.org Original Research Applying Case Definition Criteria to Irritable Bowel Syndrome Steven H. Yale, MD; A. Kenneth

More information

Accepted Article. Irritable bowel syndrome (IBS) subtypes: Nothing. Fermín Mearin Manrique. DOI: /reed /2016 Link: PDF

Accepted Article. Irritable bowel syndrome (IBS) subtypes: Nothing. Fermín Mearin Manrique. DOI: /reed /2016 Link: PDF Accepted Article Irritable bowel syndrome (IBS) subtypes: Nothing resembles less an IBS than another IBS Fermín Mearin Manrique DOI: 10.17235/reed.2016.4195/2016 Link: PDF Please cite this article as:

More information

Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population

Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population Aliment Pharmacol Ther 2005; 22: 483 488. doi: 10.1111/j.1365-2036.2005.02621.x Validated questionnaire on diagnosis and symptom severity for functional constipation in the Chinese population A. O. O.

More information

Diagnostic value of the Manning criteria in irritable bowel syndrome

Diagnostic value of the Manning criteria in irritable bowel syndrome Gut, 1990, 31, 77-81 Diagnostic value of the Manning criteria in irritable bowel syndrome 77 N J Talley, S F Phillips, L J Melton, C Mulvihill, C Wiltgen, A R Zinsmeister Gastroenterology Unit, Mayo Clinic

More information

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure: David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical

More information

Epidemiology and Impact of IBS

Epidemiology and Impact of IBS Epidemiology and Impact of IBS Speaker: Nicholas Talley Mayo Clinic Jacksonville, FL Epidemiology and Impact of IBS What is the worldwide prevalence of IBS? What is the natural history of IBS? What is

More information

What should be the primary end point in irritable bowel syndrome?

What should be the primary end point in irritable bowel syndrome? What should be the primary end point in irritable bowel syndrome? Clin. Invest. (2013) 3(2), 131 136 Irritable bowel syndrome, one of the most common gastrointestinal disorders, is characterized by abdominal

More information

Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case control study

Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case control study Aliment Pharmacol Ther 2004; 19: 233 242. doi: 10.1111/j.0269-2813.2004.01807.x Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case control study

More information

Uncomplicated diverticular disease is not a common cause of colonic symptoms

Uncomplicated diverticular disease is not a common cause of colonic symptoms Alimentary Pharmacology and Therapeutics Uncomplicated diverticular disease is not a common cause of colonic symptoms J. Y. Kang*, B. Firwana*, A. E. Green*, H. Matthews*, A. Poullis*, A. Barnabas*, L.

More information

Prevalence and management of abdominal cramping and pain: a multinational survey

Prevalence and management of abdominal cramping and pain: a multinational survey Alimentary Pharmacology & Therapeutics Prevalence and management of abdominal cramping and pain: a multinational survey E.M.M.QUIGLEY*,G.R.LOCKE, S. MUELLER-LISSNERà, L.G.PAULO,G.N.TYTGAT, I. HELFRICH**

More information

IBS - Definition. Chronic functional disorder of GI generally characterized by:

IBS - Definition. Chronic functional disorder of GI generally characterized by: IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987

More information

Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria

Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria ORIGINAL RESEARCH Prevalence of irritable bowel syndrome in Japan: Internet survey using Rome III criteria Hiroto Miwa Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College

More information

... SELECTED ABSTRACTS...

... SELECTED ABSTRACTS... ... SELECTED ABSTRACTS... The following abstracts, from medical journals containing literature on irritable bowel syndrome, were selected for their relevance to this supplement. A Technical Review for

More information

IBS: overview and assessment of pain outcomes and implications for inclusion criteria

IBS: overview and assessment of pain outcomes and implications for inclusion criteria IBS: overview and assessment of pain outcomes and implications for inclusion criteria William D. Chey, MD Professor of Medicine University of Michigan What is the Irritable Bowel Syndrome Symptom based

More information

J Neurogastroenterol Motil, Vol. 16 No. 2 April, 2010 DOI: /jnm Journal of Neurogastroenterology and Motility

J Neurogastroenterol Motil, Vol. 16 No. 2 April, 2010 DOI: /jnm Journal of Neurogastroenterology and Motility ㅋ JNM J Neurogastroenterol Motil, Vol. 16 No. 2 April, 2010 DOI: 10.5056/jnm.2010.16.2.186 Journal of Neurogastroenterology and Motility Original Article The Differences in Prevalence and Sociodemographic

More information

Vicente Garrigues, Consuelo Gálvez, Vicente Ortiz, Marta Ponce, Pilar Nos, and Julio Ponce

Vicente Garrigues, Consuelo Gálvez, Vicente Ortiz, Marta Ponce, Pilar Nos, and Julio Ponce American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 159, No. 5 Printed in U.S.A. DOI: 10.1093/aje/kwh072 PRACTICE OF EPIDEMIOLOGY

More information

WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN

WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Original Article WOMEN WITH IRRITABLE BOWEL SYNDROME ACCORDING TO ROME II CRITERIA IN JORDAN Kassab Harfoushi 1 ABSTRACT Objectives: To characterize the possible risk factors, clinical features and outcome

More information

Predictors of health care seeking for irritable bowel syndrome: a population based study

Predictors of health care seeking for irritable bowel syndrome: a population based study 394 Departments of Medicine and Psychological Medicine, University of Sydney, Nepean Hospital, PO Box 63, Penrith, NSW, Australia N J Talley PMBoyce M Jones Correspondence to: Dr N J Talley, Professor

More information

Adequate Relief in a Treatment Trial With IBS Patients: A Prospective Assessment

Adequate Relief in a Treatment Trial With IBS Patients: A Prospective Assessment Adequate Relief in a Treatment Trial With IBS Patients: A Prospective Assessment The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

More information

Medical Costs in Community Subjects With Irritable Bowel Syndrome

Medical Costs in Community Subjects With Irritable Bowel Syndrome GASTROENTEROLOGY 1995;109:1736-1741 ALIMENTARY TRACT Medical Costs in Community Subjects With Irritable Bowel Syndrome NICHOLAS J. TALLEY, SHERINE E. GABRIEL, W. SCOTT HARMSEN, ALAN R. ZINSMEISTER, and

More information

Diagnosis and Treatment of Irritable Bowel Syndrome

Diagnosis and Treatment of Irritable Bowel Syndrome Special Issue Diagnosis and Treatment of Irritable Bowel Syndrome Myung Gyu Choi, M.D. Department of Internal Medicine The Catholic University of Korea, College of Medicine Kangnam St. Mary's Hospital

More information

Fecal incontinence (FI) is a common symptom, not. Symptoms and Quality of Life in Community Women With Fecal Incontinence

Fecal incontinence (FI) is a common symptom, not. Symptoms and Quality of Life in Community Women With Fecal Incontinence CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:1004 1009 Symptoms and Quality of Life in Community Women With Fecal Incontinence ADIL E. BHARUCHA,* ALAN R. ZINSMEISTER, G. RICHARD LOCKE,* CATHY SCHLECK,

More information

IBS IBS. irritable bowel syndrome IBS IBS. in situ. E -hydroxy-l-tryptophan. -dihydroxy- -hexadien IBS IBS IBS IBS.

IBS IBS. irritable bowel syndrome IBS IBS. in situ. E -hydroxy-l-tryptophan. -dihydroxy- -hexadien IBS IBS IBS IBS. Folia Pharmacol. Jpn.119 IBS IBS in situ E -hydroxy-l-tryptophan IBS - - e-mail: yuji.iwanaga@abbott.com IBS 1. irritable bowel syndromeibs -dihydroxy- -hexadien IBS IBS IBS 2. 1 Chemical structure of

More information

REVIEW ARTICLE. Evidence- and Consensus-Based Practice Guidelines for the Diagnosis of Irritable Bowel Syndrome

REVIEW ARTICLE. Evidence- and Consensus-Based Practice Guidelines for the Diagnosis of Irritable Bowel Syndrome REVIEW ARTICLE Evidence- and Consensus-Based Practice Guidelines for the Diagnosis of Irritable Bowel Syndrome Ronnie Fass, MD; George F. Longstreth, MD; Mark Pimentel, MD; Steven Fullerton, MPH; Simcha

More information

Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN

Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN CHRONIC CONSTIPATION Definitions, Epidemiology, and Impact of Chronic Constipation Nicholas J. Talley, MD, PhD, FRACP Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Mayo

More information

Emerging Treatments for IBS-C and Clinical Trial Endpoints

Emerging Treatments for IBS-C and Clinical Trial Endpoints Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current

More information

SUPPLEMENTARY INFORMATION Associated with

SUPPLEMENTARY INFORMATION Associated with Table1: Rome III and Rome IV diagnostic criteria for IBS, functional constipation and functional dyspepsia. Rome III diagnostic criteria 1,2 Rome IV diagnostic criteria 3,4 Diagnostic criteria for IBS

More information

International Journal of Pharma and Bio Sciences V1 (2) 2010

International Journal of Pharma and Bio Sciences V1 (2) 2010 1 JOGENDER K. LALLA*, DEVEN V.PARMAR*, MEENA U.SHAH*, AND EDWARD III GROUP** *Corresponding Author j.k.lalla@gmail.com Data Requirement: Rome II Criteria for IBS Guidelines Followed: (i) Good Clinical

More information

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care

Bowel cancer risk in the under 50s. Greg Rubin Professor of General Practice and Primary Care Bowel cancer risk in the under 50s Greg Rubin Professor of General Practice and Primary Care Prevalence of GI problems in the consulting population Thompson et al, Gut 2000 Number of patients % of patients

More information

IBS current status Peter Laszlo Lakatos

IBS current status Peter Laszlo Lakatos IBS current status Peter Laszlo Lakatos Semmelweis University 1st Department of Medicine Functional gastrointestinal disorders Chronic or fluctuating functional gastrointestinal symptoms that can not be

More information

Factors Influencing Satisfaction with Life in Female Nursing College Students with Irritable Bowel Syndrome

Factors Influencing Satisfaction with Life in Female Nursing College Students with Irritable Bowel Syndrome Vol.132 (Healthcare and Nursing 2016), pp.198-203 http://dx.doi.org/10.14257/astl.2016. Factors Influencing Satisfaction with Life in Female Nursing College Students with Irritable Bowel Syndrome Sung

More information

Irritable bowel syndrome (IBS) is a ... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a ... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome ... PRESENTATION... Defining and Diagnosing Irritable Bowel Syndrome Based on a presentation by Marvin M. Schuster, MD Presentation Summary Approximately 20% of the general population has irritable bowel

More information

A Review of the Literature on Gender and Age Differences in the Prevalence and Characteristics of Constipation in North America

A Review of the Literature on Gender and Age Differences in the Prevalence and Characteristics of Constipation in North America Vol. 37 No. 4 April 2009 Journal of Pain and Symptom Management 737 Review Article A Review of the Literature on Gender and Age Differences in the Prevalence and Characteristics of Constipation in North

More information

Studies have shown that familial aggregation is of

Studies have shown that familial aggregation is of No Evidence of Sex Differences in Heritability of Irritable Bowel Syndrome in Swedish Twins Pia Svedberg, 1 Saga Johansson, 3,4 Mari-Ann Wallander, 3,6 and Nancy L. Pedersen 2,5 1 Section of Personal Injury

More information

Gastrointestinal Society 2016 SURVEY RESULTS

Gastrointestinal Society 2016 SURVEY RESULTS Gastrointestinal Society 2016 SURVEY RESULTS Irritable Bowel Syndrome (IBS) The GI (Gastrointestinal) Society represents Canadians living with gastrointestinal diseases and disorders including those who

More information

Prevalence of irritable bowel syndrome: a community survey

Prevalence of irritable bowel syndrome: a community survey Original papers Prevalence of irritable bowel syndrome: a community survey Sue Wilson, Lesley Roberts, Andrea Roalfe, Pam Bridge and Sukhdev Singh SUMMARY Background: Irritable bowel syndrome (IBS) is

More information

Why does my stomach hurt? Exploring irritable bowel syndrome

Why does my stomach hurt? Exploring irritable bowel syndrome Why does my stomach hurt? Exploring irritable bowel syndrome By Flavio M. Habal, MD, PhD, FRCPC Case In this article: 1. What is IBS? A 45-year-old female is referred to your office with recurrent 2. How

More information

Irritable Bowel Syndrome and Chronic Constipation. Treatment of IBS. Susan Lucak, M.D. Columbia University Medical Center

Irritable Bowel Syndrome and Chronic Constipation. Treatment of IBS. Susan Lucak, M.D. Columbia University Medical Center Ti tl e s l i d e - p a rt 1 Irritable Bowel Syndrome and Chronic Constipation Susan Lucak, M.D. Columbia University Medical Center Treatment of IBS Abdominal pain / discomfort Antispasmodics Antidepressants

More information

Irritable Bowel Syndrome: Toward an Understanding of Severity

Irritable Bowel Syndrome: Toward an Understanding of Severity CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:717 725 REVIEW Irritable Bowel Syndrome: Toward an Understanding of Severity ANTHONY LEMBO,* VANESSA Z. AMEEN, and DOUGLAS A. DROSSMAN *Beth Israel Deaconess

More information

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome

Effect of tegaserod on colonic transit time in male patients with constipation-predominant irritable bowel syndrome Blackwell Publishing AsiaMelbourne, AustraliaJGHJournal of Gastroenterology and Hepatology815 931926 Blackwell Publishing Asia Pty Ltd262211831189Original Article Tegaserod and colonic transit K Harish

More information

Irritable bowel syndrome (IBS) is a classic functional gastrointestinal

Irritable bowel syndrome (IBS) is a classic functional gastrointestinal CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2010;8:42 48 Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome URI LADABAUM,*, ANNIE SHARABIDZE,*, THEODORE R. LEVIN,

More information

Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China

Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China Epidemiology of Functional Diarrhea and Comparison with Diarrhea-Predominant Irritable Bowel Syndrome: A Population-Based Survey in China Yan-Fang Zhao 1., Xiao-Jing Guo 1., Zhan-Sai Zhang 2., Xiu-Qiang

More information

Mirtazapine in diarrhea-predominant irritable bowel syndrome: an openlabel

Mirtazapine in diarrhea-predominant irritable bowel syndrome: an openlabel Research Article http://www.alliedacademies.org/gastroenterology-and-digestive-diseases/ Mirtazapine in diarrhea-predominant irritable bowel syndrome: an openlabel study. Sanagapalli S 1,2*, Kim E 1, Zarate-Lopez

More information

Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints

Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:534 540 Primary Endpoints for Irritable Bowel Syndrome Trials: A Review of Performance of Endpoints MICHAEL CAMILLERI,* ALLEN W. MANGEL, SHERI E. FEHNEL,

More information

References. AMITIZA [package insert]. Bethesda, MD: Takeda Pharmaceuticals America., Inc; Takeda Pharmaceuticals America, Inc. Data on File.

References. AMITIZA [package insert]. Bethesda, MD: Takeda Pharmaceuticals America., Inc; Takeda Pharmaceuticals America, Inc. Data on File. References American College of Gastroenterology Task Force on Irritable Bowel Syndrome, Brandt LJ, Chey WD, et al. An evidence- based position statement on the management of irritable bowel syndrome. Am

More information

Irritable Bowel Syndrome. Mustafa Giaffer March 2017

Irritable Bowel Syndrome. Mustafa Giaffer March 2017 Irritable Bowel Syndrome Mustafa Giaffer March 2017 Introduction First described in 1771. 50% of patients present

More information

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation

Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation Alimentary Pharmacology and Therapeutics Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation L. Chang*, W. D. Chey, D.

More information

ICCR rotation February 7, The efficacy, safety and tolerability of tegaserod in celiac disease patients

ICCR rotation February 7, The efficacy, safety and tolerability of tegaserod in celiac disease patients The efficacy, safety and tolerability of tegaserod in celiac disease patients A. Study Purpose and Rationale: Celiac disease is an autoimmune inflammatory disease of the small intestine induced by the

More information

Results. Assessment of IBS. Determination of Concordance

Results. Assessment of IBS. Determination of Concordance GASTROENTEROLOGY 2001;121:799 804 Irritable Bowel Syndrome in Twins: Heredity and Social Learning Both Contribute to Etiology RONA L. LEVY,* KENNETH R. JONES, WILLIAM E. WHITEHEAD, SHARA I. FELD, NICHOLAS

More information

Irritable bowel syndrome (IBS) is a

Irritable bowel syndrome (IBS) is a ... REPORT... Irritable Bowel Syndrome: Toward a Cost-Effective Management Approach Robert Martin, MS, RPh; John J. Barron, PharmD; and Christopher Zacker, RPh, PhD Abstract Objective: To examine the economic

More information

COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN

COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN COMORBIDITY OF IRRITABLE BOWEL SYNDROME, PANIC DISORDER, AND AGORAPHOBIA IN THE GENERAL POPULATION IN JAPAN HIROAKI KUMANO, M.D. 1,2) Hisanobu Kaiya M.D. 1,2) Gaku Yamanaka M.D. 1,2,3) Tomifusa Kuboki

More information

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study

The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study Aliment Pharmacol Ther 2005; 22: 381 385. doi: 10.1111/j.1365-2036.2005.02566.x The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled

More information

ALMIRALL AND IRONWOOD ANNOUNCE POSITIVE RESULTS FROM A PHASE 3 TRIAL WITH LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION

ALMIRALL AND IRONWOOD ANNOUNCE POSITIVE RESULTS FROM A PHASE 3 TRIAL WITH LINACLOTIDE IN PATIENTS WITH IRRITABLE BOWEL SYNDROME WITH CONSTIPATION FOR IMMEDIATE RELEASE Ironwood Contact: Almirall Contact: Susan Brady Ketchum Pleon Corporate Communications Amanda Sefton 617.621.8304 +44 (0) 207.611.3653 sbrady@ironwoodpharma.com amanda.sefton@ketchumpleon.com

More information

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary

Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary Xifaxan, Lotronex and Viberzi Prior Authorization and Quantity Limit Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2 Lotronex (alosetron) a Indication For women with severe diarrheapredominant irritable

More information

JNM Journal of Neurogastroenterology and Motility

JNM Journal of Neurogastroenterology and Motility ㅋ JNM Journal of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 18 No. 1 January, 2012 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm.2012.18.1.70 Original Article

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 April 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 6 April 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 6 April 2011 METEOXANE, capsules B/60 (CIP code: 306 693-3) Applicant: IPRAD Simethicone Hydrated phloroglucinol ATC

More information

JNM Journal of Neurogastroenterology and Motility

JNM Journal of Neurogastroenterology and Motility JNM Journal of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 21 No. 4 October, 2015 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm15016 Original Article Validity

More information

Author's personal copy

Author's personal copy DOI 10.1007/s12664-013-0365-7 ORIGINAL ARTICLE Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: Report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study Uday C.

More information

Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider

Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Diagnosis and Management of Irritable Bowel Syndrome (IBS) For the Primary Care Provider Elizabeth Coss, MD General Gastroenterologist Audie Murphy Veterans Hospital UT Health This presentation does not

More information

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease

The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal Reflux Disease Gut and Liver, Vol. 8, No. 2, March 2014, pp. 160-164 ORiginal Article The Risk Factors and Quality of Life in Patients with Overlapping Functional Dyspepsia or Peptic Ulcer Disease with Gastroesophageal

More information

Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment

Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment REVIEW KEVIN W. OLDEN, MD Associate Professor of Medicine, Division of Gastroenterology, Mayo Clinic Scottsdale, Scottsdale, Ariz. Irritable bowel syndrome: An overview of diagnosis and pharmacologic treatment

More information

Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome

Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome Anthony Lembo, M.D. Associate Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School What is the general

More information

The burden and management of patients with IBS: results from a survey in Spanish gastroenterologists

The burden and management of patients with IBS: results from a survey in Spanish gastroenterologists 1130-0108/2011/103/11/570-575 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright 2011 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol. 103. N. 11, pp. 570-575, 2011 ORIGINAL PAPERS The burden

More information

PROSPERO International prospective register of systematic reviews

PROSPERO International prospective register of systematic reviews PROSPERO International prospective register of systematic reviews The effect of probiotics on functional constipation: a systematic review of randomised controlled trials EIRINI DIMIDI, STEPHANOS CHRISTODOULIDES,

More information

The Efficacy Of (chlordiazepoxide & clidinium) plus hyoscine N- butylbromide IN Treatment Of Irritable Bowel Syndrome

The Efficacy Of (chlordiazepoxide & clidinium) plus hyoscine N- butylbromide IN Treatment Of Irritable Bowel Syndrome The Efficacy Of (chlordiazepoxide & clidinium) plus hyoscine N- butylbromide IN Treatment Of Irritable Bowel Syndrome Hassan KH. Rajab University of Tikrit, college of medicine, Department of clinical

More information

Evaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with Diarrhea

Evaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with Diarrhea Evaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with Diarrhea January 2018 Motoko IDA Evaluation of Efficacy Variables in Clinical Study of Irritable Bowel Syndrome with

More information

ANSlmicett. Research Paper. Irritable Bowel Syndrome in Iranian Young Adults: A Survey among Medical Students

ANSlmicett. Research Paper. Irritable Bowel Syndrome in Iranian Young Adults: A Survey among Medical Students Research Paper JMS l/ssn 1682-4474) is an International, peer-reviewed scientific journal that publishes original article in experimental & clinical medicine and related disciplines such as molecular biology,

More information

Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation

Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation Current Pharmacological Treatment Options in Chronic Constipation and IBS with Constipation Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Director, GI Motility Center Beth

More information

Systematic review: the effects of fibre in the management of chronic idiopathic constipation

Systematic review: the effects of fibre in the management of chronic idiopathic constipation Alimentary Pharmacology and Therapeutics Systematic review: the effects of fibre in the management of chronic idiopathic constipation N. C. Suares* & A. C. Ford*, *Leeds Gastroenterology Institute, Leeds

More information

This is a repository copy of Pinaverium in Irritable Bowel Syndrome: Old Drug, New Tricks?.

This is a repository copy of Pinaverium in Irritable Bowel Syndrome: Old Drug, New Tricks?. This is a repository copy of Pinaverium in Irritable Bowel Syndrome: Old Drug, New Tricks?. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/97339/ Version: Accepted Version

More information

Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials

Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Clinical research Selective serotonin reuptake inhibitors for the management of irritable bowel syndrome: A meta-analysis of randomized controlled trials Roja Rahimi 1, Shekoufeh Nikfar 2, Mohammad Abdollahi

More information

Patient Satisfaction with IBS Symptom Relief Using a Novel Peppermint Oil Delivery System in a Randomized Clinical Trial and in the General Population

Patient Satisfaction with IBS Symptom Relief Using a Novel Peppermint Oil Delivery System in a Randomized Clinical Trial and in the General Population Short Communication imedpub Journals http://www.imedpub.com/ International Journal of Digestive Diseases ISSN 2472-1891 Vol. 2 No. 2: 27 http://dx.doi.org/10.4172/2472-1891.100027 Patient Satisfaction

More information

Functional bowel disorders and functional abdominal pain

Functional bowel disorders and functional abdominal pain Gut 1999;45(Suppl II):II43 II47 II43 Chair, Committee on Functional Bowel Disorders and Functional Abdominal Pain, Multinational Working Teams to Develop Diagnostic Criteria for Functional Gastrointestinal

More information

Evolving Therapy in Irritable Bowel Syndrome (IBS)

Evolving Therapy in Irritable Bowel Syndrome (IBS) Evolving Therapy in Irritable Bowel Syndrome (IBS) Dr. Syed Mohammad Arif MBBS, FCPS (Medicine), MD (Gastro) Associate Professor Department of Medicine Dhaka Medical College A good set of bowels is worth

More information

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children

Comparing the efficacy of polyethylene glycol. glycol (PEG), magnesium hydroxide, lactulose. treatment of functional constipation in children Original article Comparing the efficacy of polyethylene glycol (PEG), magnesium hydroxide and lactulosein treatment of functional constipation in children Hossein Saneian 1, Neda Mostofizadeh 2 1 Assistant

More information

pissn: eissn: Journal of Neurogastroenterology and Motility

pissn: eissn: Journal of Neurogastroenterology and Motility JNM J Neurogastroenterol Motil, Vol. 20 No. 3 July, 2014 pissn: 2093-0879 eissn: 2093-0887 http://dx.doi.org/10.5056/jnm14022 Original Article Effects of Chili Treatment on Gastrointestinal and Rectal

More information

A randomised controlled trial of a probiotic functional food in the management of irritable bowel syndrome

A randomised controlled trial of a probiotic functional food in the management of irritable bowel syndrome Roberts et al. BMC Gastroenterology 2013, 13:45 RESEARCH ARTICLE Open Access A randomised controlled trial of a probiotic functional food in the management of irritable bowel syndrome Lesley M Roberts

More information

Journal of. Prevalence of Irritable Bowel Syndrome in Morbidly Obese Individuals Seeking Bariatric Surgery

Journal of. Prevalence of Irritable Bowel Syndrome in Morbidly Obese Individuals Seeking Bariatric Surgery Journal of Gastroenterology and Hepatology Research Online Submissions: http: //www.ghrnet.org/index./joghr/ doi: 10.17554/j.issn.2224-3992.2018.07.747 Journal of GHR 2018 February 21; 7(1): 2516-2520

More information

A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation

A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation Alimentary Pharmacology & Therapeutics A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation A. WALD*, C. SCARPIGNATO, S. MUELLER-LISSNERà, M.A.KAMM,U.HINKEL,

More information

Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study

Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study Aliment Pharmacol Ther 2003; 18: 319 326. doi: 10.1046/j.1365-2036.2003.01663.x Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based

More information

Irritable bowel syndrome (IBS) is a common disorder. Effects of Multidisciplinary Education on Outcomes in Patients With Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a common disorder. Effects of Multidisciplinary Education on Outcomes in Patients With Irritable Bowel Syndrome CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2004;2:576 584 Effects of Multidisciplinary Education on Outcomes in Patients With Irritable Bowel Syndrome YURI A. SAITO,* CHARLENE M. PRATHER, CAROL T. VAN DYKE,*

More information

There is debate about how best to measure patientreported

There is debate about how best to measure patientreported GASTROENTEROLOGY 2009;137:1944 1953 Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report BRENNAN SPIEGEL,*,, MICHAEL CAMILLERI,

More information

William Chey, MD University of Michigan Ann Arbor, MI

William Chey, MD University of Michigan Ann Arbor, MI Lin Chang, MD David Geffen School of Medicine at UCLA Los Angeles, CA William Chey, MD University of Michigan Ann Arbor, MI Mark Pimentel, MD Cedars-Sinai Medical Center Los Angeles, CA Accredited by Jointly

More information

Biofeedback for Pelvic Floor Disorders and Incontinence

Biofeedback for Pelvic Floor Disorders and Incontinence The UNC Center for Functional GI & Motility Disorders www.med.unc.edu/ibs Biofeedback for Pelvic Floor Disorders and Incontinence Olafur S. Palsson, Psy.D. Associate Professor of Medicine UNC Center for

More information

Post-Infectious Irritable Bowel Syndrome. John K. Marshall MD Division of Gastroenterology McMaster University

Post-Infectious Irritable Bowel Syndrome. John K. Marshall MD Division of Gastroenterology McMaster University Post-Infectious Irritable Bowel Syndrome John K. Marshall MD Division of Gastroenterology McMaster University Pathogenesis of IBS Enck P. Nat Rev Dis Primers 2016;2:16014 Post-Infectious Irritable Bowel

More information

Primary Management of Irritable Bowel Syndrome

Primary Management of Irritable Bowel Syndrome Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)

More information

Irritable Bowel Syndrome

Irritable Bowel Syndrome Linköping University Medical Dissertations No. 974 Irritable Bowel Syndrome Diagnostic Symptom Criteria and Impact of Rectal Distensions on Cortisol and Electrodermal Activity Susanna Walter Division of

More information

University of Groningen. Hirschsprung's disease: early diagnosis and long-term outcomes Meinds, Rob

University of Groningen. Hirschsprung's disease: early diagnosis and long-term outcomes Meinds, Rob University of Groningen Hirschsprung's disease: early diagnosis and long-term outcomes Meinds, Rob IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners

Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners ORIGINAL ARTICLE Annals of Gastroenterology (18) 31, 1-6 Comparison of strategies and goals for treatment of chronic constipation among gastroenterologists and general practitioners Dan Carter a,c, Eytan

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 June 2011

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 June 2011 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 June 2011 SPASFON, film-coated tablets B/30 (CIP code: 309 860-8) SPASFON, suppositories B/10 (CIP code: 309 861-4)

More information

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES

MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:

More information

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club

Efficacy and Safety of Lubiprostone. Laura Wozniak February 23, 2010 K30 Monthly Journal Club Efficacy and Safety of Lubiprostone Laura Wozniak February 23, 2010 K30 Monthly Journal Club Objectives Brief overview of constipation Review of article Discussion Constipation in Children 3-5% of all

More information

DETERMINANTS OF PATIENT RESPONSE TO SATISFACTORY RELIEF IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. By: Skand D. Bhatt

DETERMINANTS OF PATIENT RESPONSE TO SATISFACTORY RELIEF IN PATIENTS WITH IRRITABLE BOWEL SYNDROME. By: Skand D. Bhatt DETERMINANTS OF PATIENT RESPONSE TO SATISFACTORY RELIEF IN PATIENTS WITH IRRITABLE BOWEL SYNDROME By: Skand D. Bhatt A Master's paper submitted to the faculty of the School of Public Health of the University

More information

A Meta-analysis of the Therapeutic Effects of Amitriptyline for Treating Irritable Bowel Syndrome

A Meta-analysis of the Therapeutic Effects of Amitriptyline for Treating Irritable Bowel Syndrome ORIGINAL ARTICLE A Meta-analysis of the Therapeutic Effects of Amitriptyline for Treating Irritable Bowel Syndrome Guan-qun Chao 1 and Shuo Zhang 2 Abstract Objective We aimed to evaluate the efficacy

More information